Light Based Imaging

FDA classification

FDA Class 2 ·Light Based Imaging

Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief

FDA classification

FDA Class 2 ·Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief

Crimper, Pin

FDA classification

FDA Class 1 ·Crimper, Pin

Injector, Pen

FDA classification

FDA Class 2 ·Injector, Pen

Pin, Fixation, Threaded

FDA classification

FDA Class 2 ·Pin, Fixation, Threaded

Pen, Marking, Surgical

FDA classification

FDA Class 1 ·Pen, Marking, Surgical

Pin, Fixation, Smooth

FDA classification

FDA Class 2 ·Pin, Fixation, Smooth

Driver, Surgical, Pin

FDA classification

FDA Class 1 ·Driver, Surgical, Pin

Pin, Fixation, Smooth, Metallic

FDA classification

FDA Class 2 ·Pin, Fixation, Smooth, Metallic

Pin, Fixation, Threaded, Metallic

FDA classification

FDA Class 2 ·Pin, Fixation, Threaded, Metallic

Antiserum, Positive And Negative Febrile Antigen Control Serum

FDA classification

FDA Class 2 ·Antiserum, Positive And Negative Febrile Antigen Control Serum

Filter, Conduction, Anesthetic

FDA classification

FDA Class 2 ·Filter, Conduction, Anesthetic

Pin, Fixation, Resorbable, Hard Tissue

FDA classification

FDA Class 2 ·Pin, Fixation, Resorbable, Hard Tissue

Low Power Electrosurgical Devices For Skin Lesion Destruction

FDA classification

FDA Class 2 ·Low Power Electrosurgical Devices For Skin Lesion Destruction

Pin, Retentive And Splinting, And Accessory Instruments

FDA classification

FDA Class 1 ·Pin, Retentive And Splinting, And Accessory Instruments

Ovarian Adnexal Mass Assessment Score Test System

FDA classification

FDA Class 2 ·Ovarian Adnexal Mass Assessment Score Test System

System, Digital Image Communications, Radiological

FDA classification

FDA Class 1 ·System, Digital Image Communications, Radiological

Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

FDA classification

FDA Class 2 ·Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers

FDA classification

FDA Class 2 ·Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers